138 related articles for article (PubMed ID: 21826113)
1. Changes in depressive symptoms and impact on treatment course among hepatitis C patients undergoing interferon-α and ribavirin therapy: a prospective evaluation.
Chapman J; Oser M; Hockemeyer J; Weitlauf J; Jones S; Cheung R
Am J Gastroenterol; 2011 Dec; 106(12):2123-32. PubMed ID: 21826113
[TBL] [Abstract][Full Text] [Related]
2. Depressive symptoms in patients with hepatitis C treated with pegylated interferon alpha therapy: a 24-week prospective study.
Pavlović Z; Delić D; Marić NP; Vuković O; Jašović-Gašić M
Psychiatr Danub; 2011 Dec; 23(4):370-7. PubMed ID: 22075738
[TBL] [Abstract][Full Text] [Related]
3. Role of baseline depressive symptoms in the development of depressive episode in patients receiving antiviral therapy for hepatitis C infection.
Mahajan S; Avasthi A; Grover S; Chawla YK
J Psychosom Res; 2014 Aug; 77(2):109-15. PubMed ID: 25077851
[TBL] [Abstract][Full Text] [Related]
4. Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction.
Raison CL; Borisov AS; Broadwell SD; Capuron L; Woolwine BJ; Jacobson IM; Nemeroff CB; Miller AH
J Clin Psychiatry; 2005 Jan; 66(1):41-8. PubMed ID: 15669887
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing long-term changes in mental health after interferon-alpha treatment of chronic hepatitis C.
Schmidt F; Janssen G; Martin G; Lorenz R; Loeschke K; Soyka M; Folwaczny C; Schaefer M
Aliment Pharmacol Ther; 2009 Nov; 30(10):1049-59. PubMed ID: 19691667
[TBL] [Abstract][Full Text] [Related]
6. Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C.
Galvão-de Almeida A; Quarantini LC; Sampaio AS; Lyra AC; Parise CL; Paraná R; de Oliveira IR; Koenen KC; Miranda-Scippa A; Guindalini C
Brain Behav Immun; 2011 Oct; 25(7):1491-7. PubMed ID: 21693183
[TBL] [Abstract][Full Text] [Related]
7. Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma: results from the multicenter DeCOG trial.
Heinze S; Egberts F; Rötzer S; Volkenandt M; Tilgen W; Linse R; Boettjer J; Vogt T; Spieth K; Eigentler T; Brockmeyer NH; Hinzpeter A; Hauschild A; Schaefer M
J Immunother; 2010 Jan; 33(1):106-14. PubMed ID: 19952950
[TBL] [Abstract][Full Text] [Related]
8. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
Vega Palomares R; Planas Vilà R; Durández Lazaro R; Fábregas Puigtió S
Gastroenterol Hepatol; 2002 Oct; 25(8):483-6. PubMed ID: 12361528
[TBL] [Abstract][Full Text] [Related]
9. Utility of a depression score to predict candidacy for hepatitis C virus therapy in veterans: a prospective longitudinal study.
Tavakoli-Tabasi S; Rowan P; Abdul-Latif M; Kunik ME; El-Serag HB
Aliment Pharmacol Ther; 2005 Feb; 21(3):235-42. PubMed ID: 15691297
[TBL] [Abstract][Full Text] [Related]
10. Monitoring depression in patients undergoing alpha-interferon and ribavirin therapy for hepatitis C.
Wright IA
Gastroenterol Nurs; 2000; 23(6):275-80. PubMed ID: 11854972
[TBL] [Abstract][Full Text] [Related]
11. Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C.
Raison CL; Woolwine BJ; Demetrashvili MF; Borisov AS; Weinreib R; Staab JP; Zajecka JM; Bruno CJ; Henderson MA; Reinus JF; Evans DL; Asnis GM; Miller AH
Aliment Pharmacol Ther; 2007 May; 25(10):1163-74. PubMed ID: 17451562
[TBL] [Abstract][Full Text] [Related]
12. Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin.
Hoofnagle JH; Ghany MG; Kleiner DE; Doo E; Heller T; Promrat K; Ong J; Khokhar F; Soza A; Herion D; Park Y; Everhart JE; Liang TJ
Hepatology; 2003 Jul; 38(1):66-74. PubMed ID: 12829988
[TBL] [Abstract][Full Text] [Related]
13. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
Mousa DH; Abdalla AH; Al-Shoail G; Al-Sulaiman MH; Al-Hawas FA; Al-Khader AA
Transplant Proc; 2004; 36(6):1831-4. PubMed ID: 15350490
[TBL] [Abstract][Full Text] [Related]
14. Occurrence, course and risk factors of depression during antiviral treatment for chronic hepatitis C in patients with inherited bleeding disorders: a prospective study.
Fransen Van De Putte DE; Fischer K; Posthouwer D; Van Erpecum K; Mauser-Bunschoten EP
Haemophilia; 2009 Mar; 15(2):544-51. PubMed ID: 19175422
[TBL] [Abstract][Full Text] [Related]
15. [Depressive disorders and symptoms accompanying pegylated interferon alpha and ribavirin treatment of chronic hepatitis C patients].
Pawełczyk T; Białkowska J; Jabłkowski M; Pawełczyk A; Strzelecki D; Rabe-Jabłońska J; Dworniak D
Pol Merkur Lekarski; 2008 Jun; 24(144):516-20. PubMed ID: 18702333
[TBL] [Abstract][Full Text] [Related]
16. Irritability rather than depression during interferon treatment is linked to increased tryptophan catabolism.
Russo S; Kema IP; Haagsma EB; Boon JC; Willemse PH; den Boer JA; de Vries EG; Korf J
Psychosom Med; 2005; 67(5):773-7. PubMed ID: 16204437
[TBL] [Abstract][Full Text] [Related]
17. [Depressive symptoms during treatment with interferon alpha for HCV infection--preliminary report].
Małyszczak K; Inglot M; Pawłowski T; Czarnecki M; Rymer W; Andrzej K
Psychiatr Pol; 2006; 40(4):799-808. PubMed ID: 17068951
[TBL] [Abstract][Full Text] [Related]
18. Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study.
Reichenberg A; Gorman JM; Dieterich DT
AIDS; 2005 Oct; 19 Suppl 3():S174-8. PubMed ID: 16251815
[TBL] [Abstract][Full Text] [Related]
19. Psychiatric comorbidity does not predict interferon treatment completion rates in hepatitis C seropositive veterans.
Dollarhide AW; Loh C; Leckband SG; Endow-Eyer R; Robinson S; Meyer JM
J Clin Gastroenterol; 2007 Mar; 41(3):322-8. PubMed ID: 17426475
[TBL] [Abstract][Full Text] [Related]
20. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
